company

4 HEALTH INNOVATION NORGE AS

1395 HVALSTAD

Return on Equity
150,27 %
Current Ratio
0,15
Debt-to-Equity Ratio
3,77
Key figures (NOK)2022
Revenue1 160 000
Net Income846 000
Total Assets2 851 000
Total Equity563 000
Income (NOK)2022
Revenue1 160 000
Expenditure150 000
Operating Profit1 010 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax1 010 000
Tax164 000
Net Income846 000
Balance (NOK)2022
Total Fixed Assets2 826 000
Total Current Assets24 000
Total Assets2 851 000
Total Retained Equity541 000
Total Equity563 000
Total Long-Term Debt2 124 000
Total Current Debt164 000
Total Equity and Debt2 851 000
Cash flow (NOK)2022
Sales Income1 160 000
Other Income0
Revenue1 160 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure150 000
Operating Profit1 010 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income846 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets2 826 000
Total Fixed Assets2 826 000
Stock0
Total Investments0
Cash, Bank24 000
Total Current Assets24 000
Total Assets2 851 000
Total Equity563 000
Short-Term Group Debt0
Total Long-Term Debt2 124 000
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt164 000
Total Equity and Debt2 851 000
Financial indicators2022
Return on Equity150,27 %
Debt-to-Equity Ratio3,77
Operating Profit Margin87,07 %
Current Ratio0,15
Quick Ratio0,15
Equity Ratio0,2
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English